Organon OGN
NYSE OGN
$13.75 +0.01 (+0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Organon (OGN) Non-Current Deferred Tax Liability (2020 - 2026)

Organon (OGN) posted quarterly Non-Current Deferred Tax Liability of $51.0 million for Q2 2026, down 26.09% year-over-year from $69.0 million in Q2 2025, and down 8.93% on a QoQ basis from $56.0 million in Q1 2026.

Organon (OGN) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Organon has reported Non-Current Deferred Tax Liability for 7 years, with the latest figure at $51.0 million in Q2 2026.

  • Non-Current Deferred Tax Liability for Q2 2026 came in at $51.0 million, down 26.09% year-over-year; the trailing twelve-month figure through Jun 2026 was $51.0 million (down 26.09% YoY), and the FY2025 annual result was $57.0 million, down 65.24% from the prior year.
  • Non-Current Deferred Tax Liability eased to $51.0 million in Q2 2026, from $56.0 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $164.0 million in Q4 2024 and troughed at $2.0 million in Q1 2022.
  • A 5-year average of $57.5 million and a median of $53.5 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • The widest annual swing landed in 2022, when Non-Current Deferred Tax Liability plunged 98.4%; it then surged 1400.0% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $127.0 million in 2022, then sank by 62.99% to $47.0 million in 2023, then surged by 248.94% to $164.0 million in 2024, then slumped by 65.24% to $57.0 million in 2025, then slipped by 10.53% to $51.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $51.0 million in Q2 2026, $56.0 million in Q1 2026, and $57.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Organon 3.61 Bn 2.48 Bn 847.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 51.00 Mn
Jun 30, 2026 51.00 Mn
Mar 31, 2026 56.00 Mn
Mar 31, 2026 56.00 Mn
Dec 31, 2025 57.00 Mn
Dec 31, 2025 57.00 Mn
Sep 30, 2025 62.00 Mn
Sep 30, 2025 62.00 Mn
Jun 30, 2025 69.00 Mn
Jun 30, 2025 69.00 Mn
Mar 31, 2025 69.00 Mn
Mar 31, 2025 69.00 Mn
Dec 31, 2024 74.00 Mn
Dec 31, 2024 74.00 Mn
Sep 30, 2024 56.00 Mn
Sep 30, 2024 56.00 Mn
Jun 30, 2024 60.00 Mn
Jun 30, 2024 60.00 Mn
Mar 31, 2024 44.00 Mn
Mar 31, 2024 44.00 Mn